Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2022 | 06-2021 | 06-2020 | 06-2019 | 06-2018 | |
| Sales | 325 | 500 | 2,453 | 41,692 | 24,186 |
| Gross Profit | 325 | 500 | 2,453 | 41,692 | 24,186 |
| Operating Expenses | 66,500 | 58,951 | 49,395 | 46,042 | 46,570 |
| Operating Income | -66,175 | -58,451 | -46,942 | -4,350 | -22,384 |
| Interest Expense | 2,674 | 1,506 | 11 | 0 | 0 |
| Other Income | -94 | 20 | 1,144 | 2,420 | 1,156 |
| Pre-tax Income | -68,943 | -59,937 | -45,809 | -1,930 | -21,228 |
| Income Tax | N/A | -2,108 | 83 | 76 | 72 |
| Net Income Continuous | -68,943 | -57,829 | -45,892 | -2,006 | -21,300 |
| Net Income | $-68,943 | $-57,829 | $-45,892 | $-2,006 | $-21,300 |
| EPS Basic Total Ops | -1.53 | -1.77 | -2.17 | -0.11 | -1.18 |
| EPS Basic Continuous Ops | -1.53 | -1.77 | -2.17 | -0.11 | -1.18 |
| EPS Diluted Total Ops | -1.53 | -1.77 | -2.17 | -0.11 | -1.18 |
| EPS Diluted Continuous Ops | -1.53 | -1.77 | -2.17 | -0.11 | -1.18 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.77 | -2.17 | -0.11 | -1.18 |
| EBITDA(a) | $-63,970 | $-56,610 | $-45,607 | $-3,077 | $-21,209 |